Leonard R Duncan

Antimicrobial Susceptibility of Enterobacteriaceae and Pseudomonas aeruginosa Isolates from United States Medical Centers Stratified by Infection Type: Results from the International Network for Optimal Resistance Monitoring (INFORM) Surveillance Program, 2015–2016

Hélio S. Sader, Mariana Castanheira, Leonard R Duncan et al. · Diagnostic Microbiology and Infectious Disease · 2018 · 123 citations

Life Sciences, Infectious Diseases, Microbiology +17

Ceftolozane/tazobactam activity against drug-resistant Enterobacteriaceae and Pseudomonas aeruginosa causing urinary tract and intraabdominal infections in Europe: report from an antimicrobial surveillance programme (2012–15)

Michael A. Pfaller, Matteo Bassetti, Leonard R Duncan et al. · Journal of Antimicrobial Chemotherapy · 2017 · 88 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

In Vitro Evaluation of CBR-2092, a Novel Rifamycin-Quinolone Hybrid Antibiotic: Studies of the Mode of Action in <i>Staphylococcus aureus</i>

Gregory T. Robertson, Eric J. Bonventre, Timothy B Doyle et al. · Antimicrobial Agents and Chemotherapy · 2008 · 68 citations

Pharmacy, Medicinal Chemistry, Pharmacology +17

Activity of dalbavancin and comparator agents against Gram-positive cocci from clinical infections in the USA and Europe 2015–16

Michael A. Pfaller, Rodrigo E. Mendes, Leonard R Duncan et al. · Journal of Antimicrobial Chemotherapy · 2018 · 66 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +12

In Vitro Evaluation of CBR-2092, a Novel Rifamycin-Quinolone Hybrid Antibiotic: Microbiology Profiling Studies with Staphylococci and Streptococci

Gregory T. Robertson, Eric J. Bonventre, Timothy B Doyle et al. · Antimicrobial Agents and Chemotherapy · 2008 · 61 citations

Life Sciences, Infectious Diseases, Microbiology +14